SNX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SNX is not a good buy right now for an impatient investor. The stock is in an uptrend structurally, but it’s trading just below near-term resistance (~160) with momentum cooling (MACD contracting), heavy insider selling, and short-term pattern stats pointing to weakness over the next week/month. With no Intellectia buy signals today, the risk/reward for an immediate entry is unfavorable versus waiting for a pullback toward ~154 (pivot) or below.
Trend/structure remains bullish: SMA_5 > SMA_20 > SMA_200 confirms an established uptrend. Momentum is still positive but fading: MACD histogram is above 0 (1.159) yet positively contracting, often preceding consolidation or a pullback. RSI_6 at ~65 is neutral-to-warm (not overbought), suggesting room to move but also not a clear ‘oversold buy’ setup. Price context: current 158.74 is below R1 ~160.17 (near-term resistance) and above pivot support ~153.96; a rejection near 160 could send price back to the 154 area, then S1 ~147.75 if selling accelerates. Short-horizon pattern stats also lean bearish (next week -2%, next month -6.6% expected).
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
also leans supportive from a broader positioning standpoint.
while momentum is cooling (contracting MACD), increasing the odds of a pullback toward ~154 or lower. Hedge funds are reported neutral (no supportive flow tailwind), and short-horizon statistical trend estimates point to downside over the next week/month.
Latest reported quarter: 2025/Q4. Growth trends were strong: revenue rose to 17.38B (+9.69% YoY), net income increased to 248.4M (+28.60% YoY), and EPS grew to 3.07 (+34.06% YoY). Gross margin improved to 6.87 (+4.57% YoY). Overall, the quarter shows accelerating profitability relative to revenue growth (positive operating leverage).
Recent analyst action is mildly negative on target but positive on rating: on 2025-12-17, Morgan Stanley maintained an Overweight rating while lowering its price target to $177 from $181. Wall Street pro view (based on the provided update): the bullish case is that SNX is a differentiated IT distribution/solutions asset positioned to benefit from cloud/AI infrastructure demand; the cautious angle is valuation/upside moderation implied by the lowered target and broader hardware-cycle selectivity.
Influential buyers/sellers: No recent congress trading data available; no politician transactions were provided.
